Intra-Cellular Historical Balance Sheet

ITCI
 Stock
  

USD 59.19  2.86  5.08%   

Trend analysis of Intra-Cellular Ther balance sheet accounts such as Accounts Payable of 9.4 M or Total Assets of 435.4 M provides information on Intra-Cellular Ther's total assets, liabilities, and equity, which is the actual value of Intra-Cellular Ther to its prevalent stockholders. By breaking down trends over time using Intra-Cellular Ther balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Intra-Cellular Ther prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intra-Cellular Ther is a good buy for the upcoming year.
Please see Risk vs Return Analysis.
  

About Intra-Cellular Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Intra-Cellular Ther at a specified time, usually calculated after every quarter, six months, or one year. Intra-Cellular Ther Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Intra-Cellular Ther and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Intra-Cellular currently owns. An asset can also be divided into two categories, current and non-current.

Intra-Cellular Ther Balance Sheet Chart

Intra-Cellular Ther Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Intra-Cellular Ther uses and utilizes its capital. It also shows what exactly a company owns and owes.
Intra-Cellular Ther Assets Non Current are most likely to increase significantly in the upcoming years. The last year's value of Assets Non Current was reported at 22.64 Million. The current Investments is estimated to increase to about 334.8 M, while Accumulated Other Comprehensive Income is projected to decrease to (392.7 K).

Total Assets

Total assets refers to the total amount of Intra-Cellular Ther assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Intra-Cellular Ther books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.

Current Assets

Current assets of Intra-Cellular Ther include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Intra-Cellular Ther. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Intra-Cellular Ther balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Intra-Cellular Ther books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Intra-Cellular Ther balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Intra-Cellular Ther current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Intra-Cellular Ther Assets Non Current are most likely to increase significantly in the upcoming years. The last year's value of Assets Non Current was reported at 22.64 Million. The current Investments is estimated to increase to about 334.8 M, while Accumulated Other Comprehensive Income is projected to decrease to (392.7 K).
 2021 2022 (projected)
Receivables20.16 M21.75 M
Inventories7.95 M7.34 M

Intra-Cellular Ther balance sheet Correlations

0.670.370.310.290.540.520.350.78-0.45-0.210.260.720.190.190.590.640.210.350.540.67-0.53
0.670.790.60.580.820.710.660.82-0.21-0.340.540.780.50.50.850.950.240.740.811.0-0.86
0.370.790.530.520.510.630.340.44-0.15-0.450.490.440.460.460.610.82-0.060.990.490.79-0.73
0.310.60.531.00.610.50.630.570.34-0.531.00.30.980.980.460.61-0.040.530.60.6-0.57
0.290.580.521.00.580.480.620.550.33-0.531.00.290.990.990.430.59-0.060.520.570.58-0.54
0.540.820.510.610.580.780.820.830.16-0.290.540.620.480.480.880.870.450.461.00.82-0.93
0.520.710.630.50.480.780.40.56-0.15-0.50.450.50.350.350.690.820.130.610.780.71-0.83
0.350.660.340.630.620.820.40.850.35-0.180.590.620.580.580.720.70.370.270.830.66-0.71
0.780.820.440.570.550.830.560.85-0.07-0.230.510.840.470.470.810.830.350.380.840.82-0.76
-0.45-0.21-0.150.340.330.16-0.150.35-0.07-0.030.34-0.520.380.38-0.03-0.120.16-0.10.16-0.21-0.08
-0.21-0.34-0.45-0.53-0.53-0.29-0.5-0.18-0.23-0.03-0.55-0.14-0.48-0.480.03-0.380.7-0.46-0.29-0.340.33
0.260.540.491.01.00.540.450.590.510.34-0.550.260.990.990.380.54-0.120.490.540.54-0.5
0.720.780.440.30.290.620.50.620.84-0.52-0.140.260.220.220.690.750.210.340.620.78-0.59
0.190.50.460.980.990.480.350.580.470.38-0.480.990.221.00.340.48-0.110.450.470.5-0.44
0.190.50.460.980.990.480.350.580.470.38-0.480.990.221.00.340.48-0.110.450.470.5-0.44
0.590.850.610.460.430.880.690.720.81-0.030.030.380.690.340.340.890.660.560.880.85-0.91
0.640.950.820.610.590.870.820.70.83-0.12-0.380.540.750.480.480.890.250.770.870.95-0.95
0.210.24-0.06-0.04-0.060.450.130.370.350.160.7-0.120.21-0.11-0.110.660.25-0.080.450.24-0.38
0.350.740.990.530.520.460.610.270.38-0.1-0.460.490.340.450.450.560.77-0.080.450.74-0.7
0.540.810.490.60.571.00.780.830.840.16-0.290.540.620.470.470.880.870.450.450.81-0.93
0.671.00.790.60.580.820.710.660.82-0.21-0.340.540.780.50.50.850.950.240.740.81-0.86
-0.53-0.86-0.73-0.57-0.54-0.93-0.83-0.71-0.76-0.080.33-0.5-0.59-0.44-0.44-0.91-0.95-0.38-0.7-0.93-0.86
Click cells to compare fundamentals

Intra-Cellular Ther Account Relationship Matchups

Intra-Cellular Ther balance sheet Accounts

201720182019202020212022 (projected)
Accounts Payable6.17 M13.96 M7.43 M5.5 M8.69 M9.38 M
Accumulated Other Comprehensive Income(799.22 K)(667.76 K)128.32 K480.58 K(364 K)(392.74 K)
Total Assets471.49 M357.21 M251.19 M717.31 M489.92 M435.39 M
Current Assets469.22 M355.44 M230.32 M690.9 M467.28 M419.46 M
Assets Non Current2.27 M1.77 M20.86 M26.41 M22.64 M24.43 M
Cash and Equivalents37.79 M54.95 M107.64 M61.45 M93.77 M80.4 M
Cash and Equivalents USD37.79 M54.95 M107.64 M61.45 M93.77 M80.4 M
Shareholders Equity454.44 M317.71 M195.01 M656.86 M417.89 M380.55 M
Shareholders Equity USD454.44 M317.71 M195.01 M656.86 M417.89 M380.55 M
Investments426.54 M292.58 M116.37 M597.4 M319.97 M334.8 M
Investments Current426.54 M292.58 M116.37 M597.4 M319.97 M334.8 M
Total Liabilities17.05 M39.49 M56.18 M60.45 M72.03 M77.72 M
Current Liabilities14.21 M36.3 M36.22 M36.85 M53.36 M57.57 M
Liabilities Non Current2.84 M3.19 M19.96 M23.6 M18.68 M17.32 M
Trade and Non Trade Payables6.17 M13.96 M7.43 M5.5 M8.69 M7.38 M
Property Plant and Equipment Net1.14 M1.16 M20.51 M26.32 M22.55 M24.34 M
Accumulated Retained Earnings Deficit(407.25 M)(562.38 M)(710.1 M)(937.1 M)(1.22 B)(1.25 B)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Intra-Cellular Ther without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Intra-Cellular Ther using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.6 B
Quarterly Revenue Growth YOY
1.2
Return On Assets
-0.25
Return On Equity
-0.43
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.